A carregar...

Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy

Although immunotherapy is an attractive approach for cancer treatment, increasing evidence has shown that the combination of immunotherapy with other treatment modalities may improve the outcome of advanced malignancy. We combined the anticancer drug gemcitabine (Gem) with recombinant lipoprotein-ba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Chang, Li-Sheng, Yan, Wan-Lun, Chang, Yu-Wen, Yeh, Yi-Chen, Chen, Hsin-Wei, Leng, Chih-Hsiang, Liu, Shih-Jen
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839335/
https://ncbi.nlm.nih.gov/pubmed/27141356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1095433
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!